Matthew Bunyard, MD, RhMSUS
Cleveland Clinic
Moreland Hills, OH, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Sara Tedeschi, MD, MPH
Brigham and Women's Hospital
Boston, MA, United States
Disclosure(s): Avalo Therapeutics: Consultant (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Terminated, December 19, 2022)
Update in CPPD disease classification criteria, long-term outcomes, and treatments
Speaker: Sara Tedeschi, MD, MPH – Brigham and Women's Hospital
Q&A Moderator: Matthew Bunyard, MD, RhMSUS – Cleveland Clinic
Q&A Presenter: Sara Tedeschi, MD, MPH – Brigham and Women's Hospital